FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries BromSite Recall

BromSite (bromfenac ophthalmic solution) 0

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class II
Reported by FDA
Feb 6, 2019
Recall ID
D-0422-2019
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled BromSite starting Jan 24, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0422-2019 on Feb 6, 2019. Reason: Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance. Status: Terminated.

Why it was recalled

Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance.

Product description

BromSite (bromfenac ophthalmic solution) 0.075%, 5 mL bottles, Rx Only, Distributed by : Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 49708-754-41

Lot numbers, UPCs & expiration codes

Lot #: V18E01, Exp. 05/2020

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0422-2019
Classification
Class II
Status
Terminated
Recall initiated
Jan 24, 2019
FDA report date
Feb 6, 2019
Quantity
69840 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-0422-2019, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
81958
Address
270 Prospect Plains Rd
Code information
Lot #: V18E01, Exp. 05/2020
Postal code
08512-3605
Report date
Feb 6, 2019
Product type
Drugs
Recall number
D-0422-2019
Classification
Class II
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
69840 bottles
Termination date
Feb 22, 2021
Reason for recall
Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
BromSite (bromfenac ophthalmic solution) 0.075%, 5 mL bottles, Rx Only, Distributed by : Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 49708-754-41
Distribution pattern
Nationwide within the United States
Recall initiation date
Jan 24, 2019
Initial firm notification
Letter
Center classification date
Jan 30, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0422-2019, published Feb 6, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls